isoeugenol has been researched along with Breast Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdel-Rahman, MA; Arafa, K; Arafa, RK; Elghazawy, NH; Nafie, MS; Owf, SM | 1 |
| Bilgin, S; Erden Tayhan, S; Koç, E; Yıldırım, A | 1 |
2 other study(ies) available for isoeugenol and Breast Neoplasms
| Article | Year |
|---|---|
Control of ER-positive breast cancer by ERα expression inhibition, apoptosis induction, cell cycle arrest using semisynthetic isoeugenol derivatives.
Topics: Animals; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Proliferation; Estrogen Receptor alpha; Eugenol; G2 Phase Cell Cycle Checkpoints; Gene Expression Regulation, Neoplastic; Humans; MCF-7 Cells; Mice | 2022 |
Biological Screening of Polyphenol Derivatives for Anti-Proliferative, Anti-Apoptotic and Anti-Migrative Activities in Human Breast Cancer Cell Lines MCF-7.
Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Early Detection of Cancer; Female; Humans; MCF-7 Cells; Polyphenols | 2023 |